Mylan loses patent battle to pharma rival
February 10, 2020 at 07:50 AM EST
Judges turn back the challenge to Tecfidera, the highest-selling medicine for Biogen.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|